News

FDA approves atezolizumab for adjuvant treatment of muscle invasive bladder cancer in patients with molecular residual disease

Team finds a new approach to cancer vaccination that yields more powerful T cells

ESTRO 2026: Blood test that detects tumour DNA could help guide treatment when cancer has spread

Cancer-causing protein also helps tumours repair their DNA

Experimental drug shows promise for some patients with advanced prostate cancer

New targeted radiopharmaceutical therapy induces remission in pancreatic cancer model

ESTRO 2026: AI tool for radiotherapy can support the global effort to eliminate cervical cancer

ESTRO 2026: Breast cancer that has begun to spread could be controlled for longer with targeted radiotherapy

ESTRO 2026: Just two radiotherapy sessions given over eight days can treat prostate cancer without any extra side effects

ESTRO 2026: Meeting an AI doctor before a real-life consultation improves cancer patients’ understanding and reduces stress

Study reveals why breast cancer becomes more deadly with age

ESTRO 2026: Share proton therapy across national borders and plan five new centres in Romania, Greece, Italy, Northern Ireland and Poland to maximise access for patients in Europe